Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

NCT05532852 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

728

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: standard-of-care plus Paxlovid
DRUG: standard-of-care

Sponsor

Ruijin Hospital